Tecnimede Group - Pharmaceutical Company
TECNIMEDE GROUP is composed by pharmaceutical companies of private and 100% Portuguese capital. Started its activity in 1980 and covers the entire life cycle of the medicinal products for human use: ...
Tecnimede Group - Pharmaceutical Company's Basic Information
Tecnimede Group - Pharmaceutical Company's Competitors
Farmacias Gi
Mexico
Glycyx MOR
San Francisco, California, United States
Kekule Life Sciences Limited
India
Continental Pharmacy
Miami, Florida, United States
Autico Ltd
Employee Insights
Employee Function
Employee Location
News
Never miss a headline about Tecnimede Group - Pharmaceutical Company
Track Tecnimede Group - Pharmaceutical Company's latest news, public sentiment and brand reputation in one place. Spot funding, launches, leadership changes and risk signals early, and reach out at exactly the right moment.
- ✓Real-time news & sentiment monitoring
- ✓Funding, launch and hiring signals
- ✓Timely talking points for outreach
OrgChart
Map the buying committee at Tecnimede Group - Pharmaceutical Company
See who reports to whom at Tecnimede Group - Pharmaceutical Company. Identify executives, department heads and influencers, then go straight to the right decision makers with verified contact details.
- ✓Reporting lines by department and seniority
- ✓Key decision makers and influencers
- ✓Verified emails and direct dials
Events
Meet Tecnimede Group - Pharmaceutical Company where they show up
Discover the conferences, exhibitions and webinars Tecnimede Group - Pharmaceutical Company attends, speaks at or sponsors. Turn every event into a warm conversation with the people who matter.
- ✓Upcoming and past event participation
- ✓Speakers, sponsors and attendees
- ✓Pre-event outreach lists
Tecnimede Group - Pharmaceutical Company's Top Employees
Find Your Next Customer with Better Data
Get access to over 160 million contacts and companies' information in AroundDeal's B2B database, quickly build highly targeted prospect lists and directly reach the buying committee.